Figure 1.
(A). Network graph of mean change in forced expiratory volume in 1 s per cent from baseline to four weeks. The widths of the lines are proportional to the number of studies, and the size of each circle is proportional to the sample size. TIS = tobramycin inhalation solution, AZLI = aztreonam lysine, FTI = fosfomycin/tobramycin, Col = colistin, LIS = levofloxacin. (B). Network graph of mean change in Pseudomonas sputum density from baseline to four weeks. TIS = tobramycin inhalation solution, AZLI = aztreonam lysine, TIP = tobramycin inhalation powder, Col = colistin, LIS = levofloxacin, ALIS = amikacin inhalation solution. (C). Network graph of change in CFQR-RSS, TIS = tobramycin inhalation solution, AZLI = aztreonam lysine, LIS = levofloxacin.
